Trial intelligence / Profile preview

TELNEB: Telmisartan vs Nebivolol in Hypertension

NCT02057328Phase 4Unknown

Sponsor
Aristotle University of Thessaloniki
Start
Dec 2010
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of telmisartan, nebivolol in hypertension (HTN), sponsored by Aristotle University of Thessaloniki. Status: unknown.

02

Drugs

telmisartannebivolol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02057328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02057328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call